These circumstances led to unbiased selling in emerging markets as investors sought safer assets with higher yields, further exacerbated by the strengthening of the US Dollar. The collective occurrence of these events elevated the geoeconomic risk landscape to structurally higher levels
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.